Clinical Design of ASAP-2 | tctmd.com
Xeltis | LinkedIn
EuroPCR 2017: Xeltis' Regenerated Heart Valve Shows Promising Early Preclinical Data :: Medtech Insight
Xeltis established international clinical advisory board - Cardiovascular News
Xeltis accelerating clinical trial program - Xeltis
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient | DAIC
Xeltis | LinkedIn
News - Xeltis
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Initial Clinical Trial of a Novel Pulmonary Valved Conduit - ScienceDirect
Xeltis initiates European first-in-human trial of restorative haemodialysis access graft - Renal Interventions
Xeltis initiates the first-ever pivotal trial of a synthetic restorative pulmonary heart valve - Innovation Origins
Interview – Xeltis brings bioabsorbable tech to heart valves
Xeltis - Home | Facebook
Device and Clinical Trial Update: OneShot (Covidien) | tctmd.com
Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve - Xeltis
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient | DAIC
Xeltis (@Xeltis) / Twitter
Brabant MedTech Coalition can give Xeltis an extra push forward - Innovation Origins
Xplore2 Trial Holding - Xplore 2 Trial
Xeltis trials show promising function of living heart valves restored in children
Xeltis pulmonary valved conduit implantation in the RVOT of a patient.... | Download Scientific Diagram
Xeltis - Home | Facebook
News - Xeltis
Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) | Clinical Research Trial Listing ( Multi Vessel Coronary Artery Disease ) ( NCT04545112 )
Xeltis - Home | Facebook
